EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunomodulatory actions of catecholamines, cluster-specific signaling pathways, and metabolites in pheochromocytoma and paraganglioma

Jens A Venema iD, Joanne M de Laat, Romana T Netea-Maier, Margo Dona, Henri J L M Timmers

Endocrine-Related Cancer · 01.11.2026 · 33 (11)

DOI: 10.1530/erc-26-0280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, online erschienen am 15.10.2026. Verfasst von Jens A Venema und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, Radboudumc , Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms, Catecholamines. Die Arbeit nennt 128 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine neoplasms with an exceptionally high genetic contribution, often driven by single high-penetrance mutations. Approximately one-third of patients harbor germline mutations and another third carry somatic driver mutations, allowing stratification into three molecular clusters: pseudohypoxia-related (cluster 1), kinase signaling-related (cluster 2), and Wnt signaling-related (cluster 3). These clusters differ in catecholamine secretion, malignancy, and metastatic behavior. Although PPGLs have long been viewed as immunologically ‘cold’ due to their low neoantigen load and limited T cell infiltration, recent studies show a more complex immune landscape, with differences observed between indolent and metastatic tumors and between genomic clusters. The interaction between the tumor and immune system is, in general, closely associated with tumorigenesis and disease prognosis, with both the innate and adaptive immune systems playing pivotal roles. This review summarizes how tumor-derived catecholamines and cluster-specific genetic drivers and metabolic programs are able to orchestrate immune modulation in PPGLs. Within clusters of PPGLs, distinct metabolic and signaling alterations, such as pseudohypoxia, tricarboxylic acid cycle oncometabolites, and aberrant kinase and B-catenin signaling shape both the tumor microenvironment and systemic immune response. We highlight therapeutic opportunities together with approaches that harness or reprogram innate immune memory. Recognizing PPGLs as metabolically and immunologically stratified tumors may enable rational, personalized combination therapies for patients with inoperable, recurrent, or metastatic disease and might explain the heterogeneous response to immunotherapy currently observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaParagangliomaAdrenal Gland NeoplasmsCatecholaminesHumansSignal TransductionAnimals

Stichwörter der Autor:innen

cell signalinghormone actionmolecular immunologypheochromocytoma

Substanzen

Catecholamines

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology, Radboudumc , Nijmegen, The Netherlands.
  • Institute of Biology Leiden, Leiden University , Leiden, The Netherlands.

ORCID-Profile: Jens A Venema

Zitieren

APA

Venema, J. A., de Laat, J. M., Netea-Maier, R. T., Dona, M., & Timmers, H. J. L. M. (2026). Immunomodulatory actions of catecholamines, cluster-specific signaling pathways, and metabolites in pheochromocytoma and paraganglioma. Endocrine-Related Cancer, 33(11). https://doi.org/10.1530/erc-26-0280

Vancouver

Venema JA, de Laat JM, Netea-Maier RT, Dona M, Timmers HJLM. Immunomodulatory actions of catecholamines, cluster-specific signaling pathways, and metabolites in pheochromocytoma and paraganglioma. Endocrine-Related Cancer. 2026;33(11). doi:10.1530/erc-26-0280

BibTeX
@article{Venema2026,
  author = {Venema, Jens A and de Laat, Joanne M and Netea-Maier, Romana T and Dona, Margo and Timmers, Henri J L M},
  title = {Immunomodulatory actions of catecholamines, cluster-specific signaling pathways, and metabolites in pheochromocytoma and paraganglioma},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1530/erc-26-0280}
}
Kostenlos starten →